{
    "medicine_id": "93060eaf2d72fdbd20b9cee1687b21e368d6699f",
    "platform_id": "DB05424",
    "metadata": {
        "name": "Adult Formula 50 60 61 v v Solution",
        "composition": "60 61 v v Canertinib",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in breast cancer and lung cancer",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "NA",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Canertinib"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Canertinib"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Canertinib"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Canertinib"
                    },
                    {
                        "drugbank-id": "DB00316",
                        "description": "The serum concentration of Acetaminophen can be increased when it is combined with Canertinib"
                    },
                    {
                        "drugbank-id": "DB09288",
                        "description": "The serum concentration of Propacetamol can be increased when it is combined with Canertinib"
                    },
                    {
                        "drugbank-id": "DB00017",
                        "description": "The therapeutic efficacy of Salmon calcitonin can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB00024",
                        "description": "The therapeutic efficacy of Thyrotropin alfa can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB00066",
                        "description": "The therapeutic efficacy of Follitropin can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB00279",
                        "description": "The therapeutic efficacy of Liothyronine can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB00389",
                        "description": "The therapeutic efficacy of Carbimazole can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB00451",
                        "description": "The therapeutic efficacy of Levothyroxine can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "The therapeutic efficacy of Propylthiouracil can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "The therapeutic efficacy of Methimazole can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB01583",
                        "description": "The therapeutic efficacy of Liotrix can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB03374",
                        "description": "The therapeutic efficacy of 3 5 Diiodotyrosine can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB03604",
                        "description": "The therapeutic efficacy of Tiratricol can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB05084",
                        "description": "The therapeutic efficacy of Abaloparatide can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB05829",
                        "description": "The therapeutic efficacy of Parathyroid hormone can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB06285",
                        "description": "The therapeutic efficacy of Teriparatide can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB06715",
                        "description": "The therapeutic efficacy of Potassium Iodide can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB07637",
                        "description": "The therapeutic efficacy of Dibromotyrosine can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB09100",
                        "description": "The therapeutic efficacy of Thyroid porcine can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB09418",
                        "description": "The therapeutic efficacy of Potassium perchlorate can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB09421",
                        "description": "The therapeutic efficacy of Protirelin can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB12629",
                        "description": "The therapeutic efficacy of 3 5 diiodothyropropionic acid can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB13644",
                        "description": "The therapeutic efficacy of Methylthiouracil can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB13742",
                        "description": "The therapeutic efficacy of Elcatonin can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB13804",
                        "description": "The therapeutic efficacy of Benzylthiouracil can be decreased when used in combination with Canertinib"
                    },
                    {
                        "drugbank-id": "DB15263",
                        "description": "The therapeutic efficacy of Thyrotropin can be decreased when used in combination with Canertinib"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}